ALBERATI DANIELA,ALBERATI Daniela,MOREAU JEAN-LUC,MOREAU Jean-Luc,WETTSTEIN JOSEPH G.,WETTSTEIN Joseph G.
申请号：
SI201130310
公开号：
SI2603219T1
申请日:
2011.08.05
申请国别(地区):
SI
年份:
2014
代理人:
摘要：
The present invention relates to a pharmaceutical combination of a glycine transporter inhibitor (GlyT1) and an atypical antipsychotic drug which may be used for the treatment of positive and negative symptoms of schizophrenia.
